Clinicians

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System

Huntington’s Gene Therapy Moves Back Toward the FDA Door

Alzheimer’s Research Moves Beyond Amyloid

Ebola in Congo’s Camps Shows the Human Cost of Lost Trust

Pregnancy Vaccines Become a Trust Test as Medical Societies Step In

Precision cardiology is becoming the new oncology. Policy and reimbursement must catch up

Screwworm Turns Pet Treatment Into a One Health Preparedness Issue

Chronic pain may be a cardiovascular warning sign, not just a symptom
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
